Products
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$5/mo
Lower than 55% of peersNiche median $5.99/mo
Creators
Maria Kurmacheva
No social account linked
Launched
24d ago
2026-10-27 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Expense tracker that lives in your Telegram chat

    Oct 27 · 24d agoLaunch page

    At the time: <5K visits/mo

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-03-10

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Free
$0
+1 wallet · +2 envelope budgets
Premium
$5/mo
Billed annually $30/yr-50%
Unlimited wallets and envelopes · Analytics for any period · Unlimited voice input

Trial: 7-day free trial. · 1 paid tier ($5) · Up to 50% off annually · Observed 2026-11-06 · Source page

Entry price $5/mo, Lower than 55% of peers; “Personal Finance & Budgeting” median is $5.99/mo.View pricing benchmark

Website snapshots

Indexed 2026-10-27

Key pages

Desktop & mobile archive
finpin.pro/ Snapshot 2026-11-06

Questions & evidence

How much does Finpin cost?
Free: $0; Premium: $5/mo (annual billing available). Observed 2026-11-06. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Finpin get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Finpin and what platforms does it support?
Finpin is catalogued under Personal Finance & Budgeting: Money that explains where it all goes. Supported platforms: Web.

Related products in this category

Finance / Personal Finance & Budgeting

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.